24 month longitudinal data in ambulant boys with Duchenne muscular dystrophy - Test2 - elhamkhani - TriplyDB

24 month longitudinal data in ambulant boys with Duchenne muscular dystrophy

24 month longitudinal data in ambulant boys with Duchenne muscular dystrophy

http://www.wikidata.org/entity/Q30000819

about

204th ENMC International Workshop on Biomarkers in Duchenne Muscular Dystrophy 24-26 January 2014, Naarden, The Netherlands The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence review Long term natural history data in ambulant boys with Duchenne muscular dystrophy: 36-month changes.Six-minute walk test: reference values and prediction equation in healthy boys aged 5 to 12 years.Long-Term Efficacy, Safety, and Pharmacokinetics of Drisapersen in Duchenne Muscular Dystrophy: Results from an Open-Label Extension Study Affinity proteomics within rare diseases: a BIO-NMD study for blood biomarkers of muscular dystrophies Pharmacologic management of Duchenne muscular dystrophy: target identification and preclinical trials Ataluren treatment of patients with nonsense mutation dystrophinopathy.Age-related longitudinal changes in metabolic energy expenditure during walking in boys with Duchenne muscular dystrophy.The 6 minute walk test and performance of upper limb in ambulant duchenne muscular dystrophy boys Timed Rise from Floor as a Predictor of Disease Progression in Duchenne Muscular Dystrophy: An Observational Study.Muscle Activation during Gait in Children with Duchenne Muscular Dystrophy.Identification of novel, therapy-responsive protein biomarkers in a mouse model of Duchenne muscular dystrophy by aptamer-based serum proteomics.The NorthStar Ambulatory Assessment in Duchenne muscular dystrophy: considerations for the design of clinical trials.DMD genotypes and loss of ambulation in the CINRG Duchenne Natural History Study.Circulating Biomarkers for Duchenne Muscular Dystrophy.Ongoing therapeutic trials and outcome measures for Duchenne muscular dystrophy.Development of the Performance of the Upper Limb module for Duchenne muscular dystrophy.Longitudinal community walking activity in Duchenne muscular dystrophy.Developing a Natural History Progression Model for Duchenne Muscular Dystrophy Using the Six-Minute Walk Test.Exon skipping: a first in class strategy for Duchenne muscular dystrophy.Electrical impedance myography for assessment of Duchenne muscular dystrophy.Health-related quality of life and functional changes in DMD: A 12-month longitudinal cohort study.Longitudinal effect of eteplirsen versus historical control on ambulation in Duchenne muscular dystrophy.Functional changes in Becker muscular dystrophy: implications for clinical trials in dystrophinopathies Categorizing natural history trajectories of ambulatory function measured by the 6-minute walk distance in patients with Duchenne muscular dystrophy.Spinal muscular atrophy functional composite score: A functional measure in spinal muscular atrophy.6 Minute walk test in Duchenne MD patients with different mutations: 12 month changes.Seeking a better landscape for therapy development in neuromuscular disorders.Duchenne and Becker Muscular Dystrophies: A Review of Animal Models, Clinical End Points, and Biomarker Quantification.Boys With Duchenne Muscular Dystrophy: 1-Year Locomotor Changes in Relation to a Control Group.Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management.Relationship between muscle strength and motor function in Duchenne muscular dystrophy.Fibronectin is a serum biomarker for Duchenne muscular dystrophy

P2860

Q28611318-C905805B-1EF3-473A-9AA0-47CE778A9A11 Q30234649-99CC4B8F-41B2-44FC-B71A-A4C86CCE31B3 Q30856806-2E3E71E9-8356-4AB4-9C7C-8E8332790797 Q31147166-5B5004D0-7EA1-400A-8DB3-C559A86A1CDE Q33435110-A45345DA-93FB-499E-9EA5-2C0E1777E151 Q33991470-1CB42AE0-819A-49B7-AAD2-5BA67FB6794D Q34152280-FD0483DB-3012-4AB9-80E8-BEC041443424 Q34561960-4962B56B-8FC6-4F30-BB47-099E4BFFE1F5 Q35519892-DFCFB5BE-81D8-49E5-A8DB-68CC17C68317 Q35553292-29C9BDCA-6499-4E53-AB61-82015784EB12 Q35959326-9420DDDE-0856-4A86-83F8-8F9095454AF2 Q36131331-A4A2E1EB-BDC9-4462-AC79-C3FC0BCA5BE9 Q36305436-E0E64B6B-7CD0-439A-AA61-D8D6BA93B07C Q36577433-88732FE5-AC59-4AB1-BCD6-51B54A6FFCD3 Q37158951-BE2CDDD9-7CAD-4069-B159-3825FB71F631 Q37610530-613A4C6D-1781-45D1-80DB-C153BE8B1102 Q38115148-E3D27797-1C23-457B-8BDF-95DFED352533 Q38125499-65043F43-8EC3-4C9C-AE46-9EE0E040A8F5 Q38686541-A358F5ED-162F-44DC-B884-7070EB91A01D Q38712657-85F04403-6F72-4516-BA81-BD010C1DE999 Q38784820-73366E2A-4FF7-4BD3-B9DA-AC017EC59BC1 Q39026682-F5B0B799-22D5-46B3-B1E8-52D7137421F1 Q39847054-46F319A9-DC04-4430-AC5C-A196DF6C7A7B Q40316979-4510FAC4-0054-4470-A72A-179B9B912143 Q40991213-D571E305-AEE5-4F71-B4DE-760F5C5E8F25 Q41109054-E3EEA21A-C056-44B3-B4A7-74F53B13FAAC Q41110966-FC2542DA-658B-49BF-A291-38CEC223C214 Q41860015-0D6CECE1-E921-4864-BA81-68F83DE2E9D1 Q42688781-717C141A-17FA-44FF-8B86-9CA1AD983760 Q47704855-D1C33099-3C29-40C2-9D1E-0E68D0499A33 Q48518239-647896FF-4074-45F9-A6C0-65DAB0204CE5 Q50207382-BCCF5D95-D0C9-412D-9827-B9E311EE3D0E Q53806181-14468565-C28F-4CD3-A9AA-56BFC184224D Q57389875-E2548512-1E24-4F0A-A835-BA460D08E3BA

P2860

24 month longitudinal data in ambulant boys with Duchenne muscular dystrophy

http://www.wikidata.org/entity/Q30000819

description

2013 nî lūn-bûn

@nan

2013 թուականին հրատարակուած գիտական յօդուած

@hyw

2013 թվականին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

24 month longitudinal data in ambulant boys with Duchenne muscular dystrophy

@ast

24 month longitudinal data in ambulant boys with Duchenne muscular dystrophy

@en

type

label

24 month longitudinal data in ambulant boys with Duchenne muscular dystrophy

@ast

24 month longitudinal data in ambulant boys with Duchenne muscular dystrophy

@en

prefLabel

24 month longitudinal data in ambulant boys with Duchenne muscular dystrophy

@ast

24 month longitudinal data in ambulant boys with Duchenne muscular dystrophy

@en

P1433

Q30000819-E2C0F52F-22F2-483D-9C46-BDCFE949A160

P1476

Q30000819-FFEECF86-7A6D-4053-9F37-C2B6C5A4A7C2

P2093

Q30000819-00F66E01-EDC3-4C58-A918-2FEC51D0D87F

Q30000819-02FB53C9-8BAB-4BA1-94DF-9AA419ADAC62

Q30000819-04A44800-8233-46B4-A26B-7BCE4AA0C6EA

Q30000819-1623151C-7335-4655-B4D6-775E75AFE8E7

Q30000819-23F66F75-587A-46B2-9EB5-738605A9AA4B

Q30000819-2820BCCA-0F39-454F-9B05-C00F635983D8

Q30000819-4DBB2AB2-5AFC-4B41-85B3-2571BA9FBA98

Q30000819-5C789CCF-4C17-4383-A450-2DBEE5824E8E

Q30000819-69B51D8F-AB83-4E7C-86C3-75046F2CD2AF

Q30000819-6F617218-5D27-4DF5-9EF6-E77CB85948E6

P2860

Q30000819-05EF861B-678C-4F7D-9A70-58B5390720E2

Q30000819-16675014-A49F-4D0D-8918-15D66AF88F26

Q30000819-1A79BBCC-4048-4512-893C-6B3FC8E5BAC4

Q30000819-21BB46ED-D842-44FF-A108-8BA4A6833388

Q30000819-5A13F157-2A70-4420-8B90-18AA0AC42859

Q30000819-6E8FF66C-006F-44B5-853C-1762B65AF1F4

Q30000819-88F4BAB3-98F1-415A-AEA2-D8D037854714

Q30000819-BE937C20-6706-4FAB-95BA-429B20CF717A

Q30000819-C5DFF0DD-6176-41D3-9F14-9C70E98B7AB8

P304

Q30000819-8DDABE80-0295-4284-B816-5C006DC73844

P31

Q30000819-61AC036F-3AA6-4FF3-9FFE-DFC4F5D35C9A

P3181

Q30000819-CEB7B87D-E215-4D58-98BC-4B2032F91821

P356

Q30000819-38ADFFA1-2273-41F1-BD07-418BD54634E1

P407

Q30000819-280F951A-AFB0-45DD-9EC2-8DFD77074D64

P433

Q30000819-A1604102-39CC-404B-B01B-36D966A0BABC

P478

Q30000819-CD12FF24-AE39-4BEB-B980-08AFECE10993

P50

Q30000819-0649C039-78AE-4634-99F9-FFDE4C9467F0

Q30000819-1B0FDCD3-5166-40A7-9E3E-44CC3645FD11

Q30000819-1CE0BED1-A244-4B6C-9DDF-7FE24214AB0B

Q30000819-2961D51A-3CEB-4DDC-9C2D-438296BCB28D

Q30000819-2B32EE23-3BB9-44E0-B26E-67B33FA9E1AE

Q30000819-3C394536-0822-43A4-88FE-10F63D223746

Q30000819-6C4EEC11-4BA0-4698-AA99-6E07CFE01039

Q30000819-ACF05490-F07D-4506-968B-1A45FECF8DAE

Q30000819-AF9E58CE-A154-42C9-A891-B9D45F6FEE6D

Q30000819-BA708E40-F837-4F8E-B276-C8929F524A01

P577

Q30000819-016260F8-0E55-4C66-A0D6-CCE0CBC581A2

P5875

Q30000819-AE0335C4-9F79-4A8D-AC11-775935B81489

P698

Q30000819-C101DCA5-DCAC-4988-A0DB-FA5CB60FDCAF

P932

Q30000819-53EF05B8-FB98-477B-8F39-D14454C65989

P3181

P356

JOURNAL.PONE.0052512

P1433

P1476

24 month longitudinal data in ambulant boys with Duchenne muscular dystrophy

@en

P2093

Antonella Pini

http://www.w3.org/2001/XMLSchema#string

Claudio Bruno

http://www.w3.org/2001/XMLSchema#string

Elena Pegoraro

http://www.w3.org/2001/XMLSchema#string

Elena Stacy Mazzone

http://www.w3.org/2001/XMLSchema#string

Emanuela Viggiano

http://www.w3.org/2001/XMLSchema#string

Enrica Rolle

http://www.w3.org/2001/XMLSchema#string

Filippo Cavallaro

http://www.w3.org/2001/XMLSchema#string

Flaviana Bianco

http://www.w3.org/2001/XMLSchema#string

Francesca Rossi

http://www.w3.org/2001/XMLSchema#string

Gianluca Vita

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical outcome measures for trials in Duchenne muscular dystrophy: report from International Working Group meetings

ATS statement: guidelines for the six-minute walk test.

Percent-predicted 6-minute walk distance in duchenne muscular dystrophy to account for maturational influences.

Reliability of the North Star Ambulatory Assessment in a multicentric setting.

Moving towards meaningful measurement: Rasch analysis of the North Star Ambulatory Assessment in Duchenne muscular dystrophy.

The 6-minute walk test as a new outcome measure in Duchenne muscular dystrophy.

Profiles of neuromuscular diseases. Duchenne muscular dystrophy.

Functional changes in Duchenne muscular dystrophy: a 12-month longitudinal cohort study.

North Star Ambulatory Assessment, 6-minute walk test and timed items in ambulant boys with Duchenne muscular dystrophy

P304

e52512

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3552160

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PONE.0052512

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Eugenio Mercuri

Angela Berardinelli

Francesca Magri

Stefano C. Previtali

P577

2013-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

234158873

http://www.w3.org/2001/XMLSchema#string

P698

23326337

http://www.w3.org/2001/XMLSchema#string

P932

3543414

http://www.w3.org/2001/XMLSchema#string